Karen Sweiss

15PUBLICATIONS
35CO-AUTHORS
Regenerative medicine (incl. stem cells)HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 08, 2026
Maintenance Therapy and Improved Relapse-Free Survival in Patients with Monoclonal Gammopathy of Renal Significance.

|Oct 10, 2025
Granulocyte colony-stimulating factor may improve engraftment in adults with sickle cell disease undergoing non-myeloablative haematopoietic stem cell transplantation.

Shaoshi Zhu, Lucas Maahs, Karen Sweiss

|Apr 11, 2025
Persistent opioid use is associated with a shorter myeloma survival.

Karen Sweiss, Ana Maria Avila Rodriguez, John G Quigley

|Aug 29, 2024
Comparison of patients with myeloma receiving zoledronic acid vs denosumab: a nationwide retrospective cohort study.

Ghulam Rehman Mohyuddin, Jenny S Guadamuz, Mustafa S Ascha

|Apr 03, 2024
High dose total marrow irradiation (TMI) does not increase long-term toxicity of myeloablative fludarabine/busulfan (FluBu4) conditioning regimen in allogeneic hematopoietic stem cell transplantation (HSCT).

Lucas Maahs, Pritesh Patel, Matthew Koshy

|Nov 09, 2023
Patterns of prescription opioid use and opioid-related harms among adult patients with hematologic malignancies.

Nadia A Nabulsi, Lisa K Sharp, Karen I Sweiss

Pageof 3

Frequent Collaborators

8 joint publications

Gregory Sampang Calip

3 joint publications

Pritesh R Patel

2 joint publications

Brian C-H Chiu

1 joint publications

Inyoung Lee